Clover Health Investments, CORP /DE Form 4 insider transactions

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the disposal of shares to cover tax obligations upon vesting of restricted stock units.

Jamie Reynoso, CEO of Medicare Advantage at Clover Health, disposed of 21,578 shares of Class A Common Stock on January 31, 2025, to cover tax obligations related to vesting restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of 18,987 shares of Class A Common Stock on January 31, 2025, to cover tax obligations related to vesting restricted stock units.

CEO of Clover Health, Conrad Wai, disposed of 24,470 shares of Class A Common Stock to cover tax obligations arising from the vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of 38,560 shares of Class A Common Stock on January 18, 2025, to cover tax obligations related to vesting restricted stock units.

Director Vivek Garipalli of Clover Health Investments, Corp. executed transactions involving Class A and Class B common stock following the vesting of restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, sold shares to cover tax obligations related to vesting restricted stock units.

Jamie Reynoso, CEO of Clover Health, disposed of 17,142 shares of Class A Common Stock on January 7, 2025, to cover tax obligations related to vesting restricted stock units.

Director Carladenise Edwards reports acquisition of 60,975 Class A Common Stock restricted stock units (RSUs) in Clover Health Investments, Corp.

William G. Robinson Jr., a director at Clover Health Investments, acquired 60,975 shares of Class A Common Stock through the vesting of restricted stock units.

Director Thomas L. Tran acquired 60,975 shares of Clover Health Class A Common Stock through a restricted stock unit grant that vests on January 6, 2026.

Director Anna U. Loengard reports acquisition of restricted stock units and adjustments to indirect beneficial ownership of Clover Health Investments Corp. shares.

Director Lee Shapiro reports acquisition of 60,975 Class A Common Stock units from Clover Health Investments, Corp.

Chelsea Clinton, a director of Clover Health Investments, reported the acquisition of 60,975 shares of Class A common stock on January 6, 2025, as part of a restricted stock unit award.

Demetrios L. Kouzoukas, a director at Clover Health Investments, Corp., acquired 60,975 shares of Class A Common Stock through a grant of restricted stock units.

Jamie Reynoso, CEO of Clover Health, disposed of shares to cover tax obligations related to vesting restricted stock units.

Andrew Toy, CEO of Clover Health, reports the disposal of shares to cover tax obligations related to vesting restricted stock units.

Karen Soares, General Counsel & Secretary at Clover Health, reported a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.

Conrad Wai, CEO of Counterpart Health and an officer at Clover Health Investments, sold 98,217 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, disposed of shares to cover tax obligations related to vesting restricted stock units.

Karen Soares, General Counsel & Secretary at Clover Health Investments, sold 7,444 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Andrew Toy, CEO of Clover Health, disposed of 85,367 shares of Class A Common Stock on November 8, 2024, to cover tax obligations related to the vesting of restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the disposal of shares to cover tax obligations upon vesting of restricted stock units.

CEO of Counterpart Health, Conrad Wai, reports the disposal of shares to cover tax obligations upon vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of shares to cover tax obligations upon the vesting of restricted stock units.

Clover Health CEO Jamie Reynoso sold 118,050 shares of Class A Common Stock on October 31, 2024, to cover tax obligations related to the vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, sold 48,305 shares of Class A Common Stock on October 18, 2024, to cover tax obligations related to vesting restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the acquisition of restricted stock units (RSUs) and changes in beneficial ownership of Class A Common Stock.

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, reports acquiring shares of Class A Common Stock through a restricted stock unit award.

Brady Priest, CEO of Home Care at Clover Health, reports acquiring 726,114 shares of Class A Common Stock on October 15, 2024, resulting in a total beneficial ownership of 2,699,323 shares.